Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion description "[Hematological and cytogenetic response of interferon alpha 2b alone and combined interferon alpha plus cytarabine as a first-line treatment in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion evidence source_evidence_literature NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion SIO_000772 10985480 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion wasDerivedFrom befree-20150227 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_assertion wasGeneratedBy ECO_0000203 NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP477213.RAdQbvsu6mKLsH4U5f3i4prKq3wcR2h45iWewtiA8rBjY130_provenance.